Dr. Karen Pierce is one of PanCAN’s biggest cheerleaders. That’s why Karen knew to contact PanCAN when her husband, Dr. Carey Weiss, was diagnosed with pancreatic cancer in 2019 — and she’s incredibly ...
If there’s a way to shine a light on PanCAN, Marco Argenti has done it. This year, Marco added Team PanCAN to the list, running the New York City Half Marathon in March and, during Pancreatic Cancer ...
This Pancreatic Cancer Awareness Month, PanCAN is inviting you to shine a light on pancreatic cancer. Let’s uplift survivors and those living with the disease, honor the lives we’ve lost and help ...
Ask any caregiver what keeps them going, and you will hear a common answer: love. Caregivers support people living with pancreatic cancer in every way imaginable — from lending a listening ear and ...
Editor’s note: In this heartfelt interview, Jaylen Baron shares the story of her mother, Jane – an inspiring dance teacher, mentor and fighter – whose legacy is honored every year at PanCAN ...
The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called PNET or PanNET. “I am delighted that patients with pancreatic ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...
The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...
Read this story in English. Nota del editor: Durante el mes de la herencia hispana, que corre desde el 15 de Septiembre hasta el 15 de Octubre, estamos destacando nuestros servicios gratuitos y ...
PanCAN’s new Chief Scientific and Medical Officer, Anna Berkenblit, MD, MMSc, has nearly 20 years of experience bringing new therapies to patients with cancer. She’s served in leadership roles in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback